Description
DROXIDOPA
First action · last action
2019-03-19 · 2019-08-13
Transactions
3
First transaction's obligation
$117,669
Base + all options value (sum of deltas)
$180,462
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-03-19+$117,669= $117,669
- Mod P000012019-04-18+$62,534= $180,203
- Mod P000022019-08-13+$259= $180,462
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-03-19 | +$117,669 | $117,669 | DROXIDOPA |
| Mod P00001· FUNDING ONLY ACTION | 2019-04-18 | +$62,534 | $180,203 | DROXIDOPA |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2019-08-13 | +$259 | $180,462 | DROXIDOPA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JCVFNPM8CNS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0942 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
| 36C24226P0847 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
| 36C24226P0786 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
| 36C24226P0705 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
| 36C24226P0630 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $17,614 | FY2026 |
| 36C24226P0547 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026P0118 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $30,935 | FY2026 |
| 36C77026P0129 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $76,656 | FY2026 |
| 36C77026P0127 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $58,395 | FY2026 |
| 36C77026P0086 | SAGENT PHARMACEUTICALS, INC | NATIONAL CMOP OFFICE (36C770) | $275,580 | FY2026 |
| 36C77026P0095 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $83,520 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77019P0650_3600_-NONE-_-NONE- · retrieved 2026-09-26.